Status:
RECRUITING
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
Lead Sponsor:
Emory University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Congenital Heart Disease
Tetralogy of Fallot
Eligibility:
All Genders
Up to 20 years
Brief Summary
The study team will use small pieces of human hearts which are removed as part of a required surgical procedure to study different objectives. One of the objective is how calcium ions pass through the...
Detailed Description
Extrapolating pharmacological and surgical therapies from adult (AD) studies to infant (INF) patients is problematic because the knowledge of cellular electrophysiology and molecular biology of human ...
Eligibility Criteria
Inclusion
- Patients undergoing cardiopulmonary bypass surgery
- Patients undergoing surgery for repair of congenital heart disease such as ventricular septal defect or defective mitral or aortic valves.
Exclusion
- Prior cardiac surgery
- History of atrial fibrillation or other atrial arrhythmias prior to operation
- History of heart failure
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00243776
Start Date
April 1 2005
End Date
December 31 2025
Last Update
June 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University School of Medicine
Atlanta, Georgia, United States, 30322